LifeTech Scientific Statistics
Total Valuation
LifeTech Scientific has a market cap or net worth of HKD 7.92 billion. The enterprise value is 6.88 billion.
Market Cap | 7.92B |
Enterprise Value | 6.88B |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
LifeTech Scientific has 4.63 billion shares outstanding. The number of shares has increased by 0.56% in one year.
Shares Outstanding | 4.63B |
Shares Change (YoY) | +0.56% |
Shares Change (QoQ) | +1.39% |
Owned by Insiders (%) | 15.95% |
Owned by Institutions (%) | 17.08% |
Float | 3.89B |
Valuation Ratios
The trailing PE ratio is 28.54 and the forward PE ratio is 22.21.
PE Ratio | 28.54 |
Forward PE | 22.21 |
PS Ratio | 5.40 |
PB Ratio | 2.15 |
P/FCF Ratio | 486.45 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.82, with an EV/FCF ratio of 422.47.
EV / Earnings | 25.74 |
EV / Sales | 5.00 |
EV / EBITDA | 18.82 |
EV / EBIT | 24.47 |
EV / FCF | 422.47 |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.03.
Current Ratio | 2.68 |
Quick Ratio | 1.52 |
Debt / Equity | 0.03 |
Debt / EBITDA | 0.31 |
Debt / FCF | 6.89 |
Interest Coverage | 203.61 |
Financial Efficiency
Return on equity (ROE) is 2.43% and return on invested capital (ROIC) is 4.85%.
Return on Equity (ROE) | 2.43% |
Return on Assets (ROA) | 3.69% |
Return on Capital (ROIC) | 4.85% |
Revenue Per Employee | 973,051 |
Profits Per Employee | 188,937 |
Employee Count | 1,448 |
Asset Turnover | 0.29 |
Inventory Turnover | 0.62 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -26.47% in the last 52 weeks. The beta is 0.82, so LifeTech Scientific's price volatility has been lower than the market average.
Beta (5Y) | 0.82 |
52-Week Price Change | -26.47% |
50-Day Moving Average | 1.51 |
200-Day Moving Average | 1.71 |
Relative Strength Index (RSI) | 57.51 |
Average Volume (20 Days) | 45,920,301 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, LifeTech Scientific had revenue of HKD 1.38 billion and earned 267.16 million in profits. Earnings per share was 0.06.
Revenue | 1.38B |
Gross Profit | 1.08B |
Operating Income | 282.01M |
Pretax Income | 137.33M |
Net Income | 267.16M |
EBITDA | 354.80M |
EBIT | 282.01M |
Earnings Per Share (EPS) | 0.06 |
Balance Sheet
The company has 1.12 billion in cash and 112.20 million in debt, giving a net cash position of 1.01 billion or 0.22 per share.
Cash & Cash Equivalents | 1.12B |
Total Debt | 112.20M |
Net Cash | 1.01B |
Net Cash Per Share | 0.22 |
Equity (Book Value) | 3.64B |
Book Value Per Share | 0.79 |
Working Capital | 1.50B |
Cash Flow
In the last 12 months, operating cash flow was 319.76 million and capital expenditures -303.48 million, giving a free cash flow of 16.28 million.
Operating Cash Flow | 319.76M |
Capital Expenditures | -303.48M |
Free Cash Flow | 16.28M |
FCF Per Share | 0.00 |
Margins
Gross margin is 78.58%, with operating and profit margins of 20.50% and 19.42%.
Gross Margin | 78.58% |
Operating Margin | 20.50% |
Pretax Margin | 9.98% |
Profit Margin | 19.42% |
EBITDA Margin | 25.79% |
EBIT Margin | 20.50% |
FCF Margin | 1.18% |
Dividends & Yields
LifeTech Scientific does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.56% |
Shareholder Yield | -0.56% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on January 12, 2015. It was a forward split with a ratio of 8.
Last Split Date | Jan 12, 2015 |
Split Type | Forward |
Split Ratio | 8 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |